Evaluating GM biofortified rice in areas with a high prevalence of folate deficiency Online publication date:: Thu, 30-Apr-2015
by Hans De Steur; Manoj Kumar Dora; Dieter Blancquaert; Ge Liqun; Willy Lambert; Dominique Van Der Straeten; Xavier Gellynck
International Journal of Biotechnology (IJBT), Vol. 13, No. 4, 2014
Abstract: Folate biofortified rice is considered a novel strategy to reduce the burden of folate deficiency. This study quantifies the possible health benefits of introducing this GM crop in two regions at high risk of folate deficiency and neural-tube defects, namely Balrampur (India) and Shanxi (China). By measuring the number of disability-adjusted life years (DALYs) lost, the results not only highlight the problematic situation in these regions, but also demonstrate the effectiveness of folate biofortification, which could save between 29-111 DALYs (Balrampur) and between 47-104 DALYs per 1,000 births (Shanxi). A sensitivity analysis underlines the impact of the parameters of the DALY framework.
Online publication date:: Thu, 30-Apr-2015
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email firstname.lastname@example.org